reviewNature reviews. ImmunologyAug 22, 2014GREEN OA

The IL-23–IL-17 immune axis: from mechanisms to therapeutic testing

SLSarah L. Gaffen RJRenu Jain AVAbhishek V. GargDJDaniel J. Cua

Rheumatology Consultants · Merck & Co., Inc., Rahway, NJ, USA (United States)

Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,524

total citations

FWCI: 53.12
Percentile: 100%
References: 187

Citations per year

Authors

4

SL
Sarah L. GaffenCorresponding
Rheumatology Consultants
RJ
Renu Jain
Merck & Co., Inc., Rahway, NJ, USA (United States)
AV
Abhishek V. Garg
Rheumatology Consultants
DJ
Daniel J. Cua
Merck & Co., Inc., Rahway, NJ, USA (United States)

Topics & keywords

Topics

Keywords

Immune system
Effector
Interleukin 23
Biology
Immunology
Mesenchymal stem cell
Lineage (genetic)
Interleukin 17

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.